Cortisol and testosterone in hair as biological markers of systolic heart failure

Psychoneuroendocrinology

Volumn 38, Issue 12, 2013, Pages 2875-2882

  Pereg, David ^a   Chan, Justin ^b   Russell, Evan ^b   Berlin, Tatiana ^a   Mosseri, Morris ^a   Seabrook, Jamie A ^c,d   Koren, Gideon ^b   Van Uum, Stan ^d  

^a TEL AVIV UNIVERSITY   (Israel)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c CHILDREN S HEALTH RESEARCH INSTITUTE   (Canada)

^d WESTERN UNIVERSITY   (Canada)

Author keywords

Cortisol; Hair analysis; Heart failure; Prognosis; Testosterone

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; HYDROCORTISONE; TESTOSTERONE;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EXERCISE TEST; HAIR LEVEL; HEART LEFT VENTRICLE EJECTION FRACTION; HORMONE DETERMINATION; HOSPITALIZATION; HUMAN; MALE; NEW YORK HEART ASSOCIATION CLASS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SCALP HAIR; STEROIDOGENESIS; SYSTOLIC HEART FAILURE; TREADMILL EXERCISE;

CORTISOL; HAIR ANALYSIS; HEART FAILURE; PROGNOSIS; TESTOSTERONE;

AGED; BIOLOGICAL MARKERS; ECHOCARDIOGRAPHY; ENDPOINT DETERMINATION; EXERCISE TEST; FEMALE; HAIR; HEART FAILURE, SYSTOLIC; HUMANS; HYDROCORTISONE; IMMUNOASSAY; MALE; PROGNOSIS; STROKE VOLUME; TESTOSTERONE; VENTRICULAR FUNCTION, LEFT;

EID: 84888302132     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2013.07.015     Document Type: Article

References (39)

1. Anker S.D., Clark A.L., Kemp M., Salsbury C., Teixeira M.M., Hellewell P.G., Coats A.J. Tumor Necrosis factor and steroid metabolism in chronic heart failure: possible relation to muscle wasting. J. Am. Coll. Cardiol. 1997, 30:997-1001.
2. Arnlöv J., Pencina M.J., Amin S., Nam B.H., Benjamin E.J., Murabito J.M., Wang T.J., Knapp P.E., D'Agostino R.B., Bhasin S., Vasan R.S. Endogenous sex hormones and cardiovascular disease incidence in men. Ann. Intern. Med. 2006, 145:176-184.
3. Brambilla D.J., O'Donnell A.B., Matsumoto A.M., McKinlay J.B. Intraindividual variation in levels of serum testosterone and other reproductive and adrenal hormones in men. Clin. Endocrinol. (Oxf.) 2007, 67:853-862.
4. Brambilla D.J., Matsumoto A.M., Araujo A.B., McKinlay J.B. The effect of diurnal variation on clinical measurement of serum testosterone and other sex hormone levels in men. J. Clin. Endocrinol. Metab. 2009, 94:907-913.
5. Brotman D., Golden S.H., Wittstein I.S. The cardiovascular toll of stress. Lancet 2007, 370:1089-1098.
6. Brunner E.J., Hemingway H., Walker B.R., Page M., Clarke P., Juneja M., Shipley M.J., Kumari M., Andrew R., Seckl J.R., Papadopoulos A., Checkley S., Rumley A., Lowe G.D., Stansfeld S.A., Marmot M.G. Adrenocortical autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study. Circulation 2002, 106:2659-2665.
7. Caminiti G., Volterrani M., Iellamo F., Marazzi G., Massaro R., Miceli M., Mammi C., Piepoli M., Fini M., Rosano G.M. Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study. J. Am. Coll. Cardiol. 2009, 54:919-927.
8. Choong K., Basaria S. Emerging cardiometabolic complications of androgen deprivation therapy. Aging Male 2010, 13:1-9.
9. Contoreggi C.S., Blackman M.R., Andres R., Muller D.C., Lakatta E.G., Fleg J.L., Harman S.M. Plasma levels of estradiol, testosterone, and DHEAS do not predict risk of coronary artery disease in men. J. Androl. 1990, 11:460-470.
10. Davenport M.D., Lutz C.K., Tiefenbacher S., Novak M.A., Meyer J.S. A rhesus monkey model of self-injury: effects of relocation stress on behavior and neuroendocrine function. Biol. Psychiatry 2008, 63:990-996.
11. Gow R., Koren G., Rieder M., Van Uum S. Hair cortisol content in patients with adrenal insufficiency on hydrocortisone replacement therapy. Clin. Endocrinol. (Oxf.) 2011, 74:687-693.
12. Güder G., Bauersachs J., Frantz S., Weismann D., Allolio B., Ertl G., Angermann C.E., Störk S. Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure. Circulation 2007, 115:1754-1761.
13. Güder G., Frantz S., Bauersachs J., Allolio B., Ertl G., Angermann C.E., Störk S. Low circulating androgens and mortality risk in heart failure. Heart 2010, 96:504-509.
14. Haring R., Teng Z., Xanthakis V., Coviello A., Sullivan L., Bhasin S., Murabito J.M., Wallaschofski H., Vasan R.S. Association of sex steroids, gonadotrophins, and their trajectories with clinical cardiovascular disease and all-cause mortality in elderly men from the Framingham Heart Study. Clin. Endocrinol. (Oxf.) 2013, 78(4):629-634.
15. Iellamo F., Volterrani M., Caminiti G., Karam R., Massaro R., Fini M., Collins P., Rosano G.M. Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study. J. Am. Coll. Cardiol. 2010, 56:1310-1316.
16. Jankowska E.A., Biel B., Majda J., Szklarska A., Lopuszanska M., Medras M., Anker S.D., Banasiak W., Poole-Wilson P.A., Ponikowski P. Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival. Circulation 2006, 114:1829-1837.
17. Jankowska E.A., Filippatos G., Ponikowska B., Borodulin-Nadzieja L., Anker S.D., Banasiak W., Poole-Wilson P.A., Ponikowski P. Reduction in circulating testosterone relates to exercise capacity in men with chronic heart failure. J. Card. Fail. 2009, 15:442-450.
18. Liu P.Y., Death A.K., Handelsman D.J. Androgens and cardiovascular disease. Endocr. Rev. 2003, 24:313-340.
19. Malkin C.J., Pugh P.J., West J.N., van Beek E.J., Jones T.H., Channer K.S. Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial. Eur. Heart J. 2006, 27:57-64.
20. Manenschijn L., Koper J.W., van den Akker E.L., de Heide L.J., Geerdink E.A., de Jong F.H., Feelders R.A., van Rossum E.F. A novel tool in the diagnosis and follow-up of (cyclic) Cushing's syndrome: measurement of long-term cortisol in scalp hair. J. Clin. Endocrinol. Metab. 2012, 97(10):E1836-E1843.
21. Manenschijn L., Schaap L., van Schoor N.M., van der Pas S., Peeters G.M., Lips P., Koper J.W., van Rossum E.F. High long-term cortisol levels, measured in scalp hair, are associated with a history of cardiovascular disease. J. Clin. Endocrinol. Metab. 2013, 98(5):2078-2083.
22. Moriyama Y., Yasue H., Yoshimura M., Mizuno Y., Nishiyama K., Tsunoda R., Kawano H., Kugiyama K., Ogawa H., Saito Y., Nakao K. The plasma levels of dehydroepiandrosterone sulfate are decreased in patients with chronic heart failure in proportion to the severity. J. Clin. Endocrinol. Metab. 2000, 85:834-840.
23. O'Connor C.M., Whellan D.J., Wojdyla D., Leifer E., Clare R.M., Ellis S.J., Fine L.J., Fleg J.L., Zannad F., Keteyian S.J., Kitzman D.W., Kraus W.E., Rendall D., Piña I.L., Cooper L.S., Fiuzat M., Lee K.L. Factors related to morbidity and mortality in patients with chronic heart failure with systolic dysfunction: the HF-ACTION predictive risk score model. Circ. Heart Fail. 2012, 5:63-71.
24. Pastor-Pérez F.J., Manzano-Fernández S., Garrido-Bravo I.P., Nicolás F., Tornel P.L., Lax A., de la Morena G., Valdés M., Pascual-Figal D.A. Anabolic status and functional impairment in men with mild chronic heart failure. Am. J. Cardiol. 2011, 108:862-866.
25. Pereg D., Gow R., Mosseri M., Lishner M., Rieder M., Van Uum S., Koren G. Hair cortisol and the risk for acute myocardial infarction. Stress 2011, 14:73-81.
26. Pocock S.J., Wang D., Pfeffer M.A., Yusuf S., McMurray J.J., Swedberg K.B., Ostergren J., Michelson E.L., Pieper K.S., Granger C.B. Predictors of mortality and morbidity in patients with chronic heart failure. Eur. Heart J. 2006, 27:65-75.
27. Pugh P.J., Jones R.D., West J.N., Jones T.H., Channer K.S. Testosterone treatment for men with chronic heart failure. Heart 2004, 90:446-447.
28. Sauvé B., Koren G., Walsh G., Tokmakejian S., Van Uum S.H. Measurement of cortisol in human hair as a biomarker of systemic exposure. Clin. Invest. Med. 2007, 30:E183-E191.
29. Smith G.D., Ben-Shlomo Y., Beswick A., Yarnell J., Lightman S., Elwood P. Cortisol, testosterone, and coronary heart disease: prospective evidence from the Caerphilly study. Circulation 2005, 112(3):332-340.
30. Stalder T., Kirschbaum C., Heinze K., Steudte S., Foley P., Tietze A., Dettenborn L. Use of hair cortisol analysis to detect hypercortisolism during active drinking phases in alcohol-dependent individuals. Biol. Psychol. 2010, 85(3):357-360.
31. Stalder T., Kirschbaum C., Alexander N., Bornstein S.R., Gao W., Miller R., Stark S., Bosch J.A., Fischer J.E. Cortisol in hair and the metabolic syndrome. J. Clin. Endocrinol. Metab. 2013, 98(6):2573-2580.
32. Traish A.M., Miner M.M., Morgentaler A., Zitzmann M. Testosterone deficiency. Am. J. Med. 2011, 124:578-587.
33. Thomson S., Koren G., Van Steen V., Rieder M., Van Uum S.H. Testosterone concentrations in hair of hypogonadal men with and without testosterone replacement therapy. Ther. Drug Monit. 2009, 31:779-782.
34. Thomson S., Koren G., Fraser L.A., Rieder M., Friedman T.C., Van Uum S.H. Hair analysis provides a historical record of cortisol levels in Cushing's syndrome. Exp. Clin. Endocrinol. Diab. 2010, 118:133-138.
35. Ullah M.I., Washington T., Kazi M., Tamanna S., Koch C.A. Testosterone deficiency as a risk factor for cardiovascular disease. Horm. Metab. Res. 2011, 43:153-164.
36. Van Uum S.H., Sauvé B., Fraser L.A., Morley-Forster P., Paul T.L., Koren G. Elevated content of cortisol in hair of patients with severe chronic pain: a novel biomarker for stress. Stress 2008, 11:483-488.
37. Wehr E., Pilz S., Boehm B.O., März W., Grammer T., Obermayer-Pietsch B. Low free testosterone is associated with heart failure mortality in older men referred for coronary angiography. J. Heart Fail. 2011, 13:482-488.
38. Working Group on Cardiac Rehabilitation Excercise Physiology Working Group on Heart Failure of the European Society of Cardiology Recommendations for exercise testing in chronic heart failure patients. Eur. Heart J. 2001, 22:37-45.
39. Yamada J., Stevens B., de Silva N., Gibbins S., Beyene J., Taddio A., Newman C., Koren G. Hair cortisol as a potential biologic marker of chronic stress in hospitalized neonates. Neonatology 2007, 92:42-49.